<html>
<head>PUBMED IDs for MDS1-EVI1</head>
<body bgcolor='#C5F0F2'><h1>MDS1-EVI1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/8643684/'>Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.</a> February 20  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/8661032/'>Physical mapping of the retinoblastoma interacting zinc finger gene RIZ to D1S228 on chromosome 1p36.</a> May 15  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/8921366/'>The B-lymphocyte maturation promoting transcription factor BLIMP1/PRDI-BF1 maps to D6S447 on human chromosome 6q21-q22.1 and the syntenic region of mouse chromosome 10.</a> October 1  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/9006946/'>The retinoblastoma interacting zinc finger gene RIZ produces a PR domain-lacking product through an internal promoter.</a> January 31  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9307271/'>Activation of a novel gene in 3q21 and identification of intergenic fusion transcripts with ecotropic viral insertion site I in leukemia.</a> October 27  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9632640/'>The PR domain of the Rb-binding zinc finger protein RIZ1 is a protein binding interface and is related to the SET domain functioning in chromatin-mediated gene expression.</a> June 20  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9837768/'>Comparative expression analysis of the antagonistic transcription factors EVI1 and MDS1-EVI1 in murine tissues and during in vitro hematopoietic differentiation.</a> December 5  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/11503956/'>Chromosome and molecular abnormalities in myelodysplastic syndromes.</a> August 16  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12393383/'>High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients.</a> October 24  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12626569/'>Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines.</a> March 11  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14585371/'>Low expression of MDS1-EVI1-like-1 (MEL1) and EVI1-like-1 (EL1) genes in favorable-risk acute myeloid leukemia.</a> October 31  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15326310/'>The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin.</a> August 25  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16582916/'>Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.</a> April 4  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18227842/'>The MDS1-EVI1 gene complex as a retrovirus integration site: impact on behavior of hematopoietic cells and implications for gene therapy.</a> January 30  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19027486/'>Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.</a> November 26  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19027483/'>Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial.</a> November 26  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19027472/'>Gefitinib or docetaxel in advanced non-small-cell lung cancer.</a> November 26  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/20512145/'>A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci.</a> August 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21878903/'>Retroviral gene therapy for X-linked chronic granulomatous disease: results from phase I/II trial.</a> March 6  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22039883/'>Targeting a DNA binding motif of the EVI1 protein by a pyrrole-imidazole polyamide.</a> January 27  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/24021671/'>Essential role of PR-domain protein MDS1-EVI1 in MLL-AF9 leukemia.</a> December 18  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24495476/'>The role of EVI1 in myeloid malignancies.</a> January 7  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24615621/'>Multigene pathway-based analyses identify nasopharyngeal carcinoma risk associations for cumulative adverse effects of TERT-CLPTM1L and DNA double-strand breaks repair.</a> October 21  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25959919/'>EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor-Î²-mediated growth inhibition in hepatocellular carcinoma.</a> October 7  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26554871/'>Congenital thrombocytopenia in a neonate with an interstitial microdeletion of 3q26.2q26.31.</a> October 26  2015<br></body></html>
